These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 168912)

  • 21. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. II. Altered gp70 display and production of noninfectious virus particles by an insusceptible variant tumor.
    Green WR; Brown MA
    Eur J Immunol; 1983 Nov; 13(11):871-7. PubMed ID: 6196207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spontaneous and induced appearance of murine leukemia virus antigen containing cells in organ cultures of embryonic mouse thymus.
    Riesenfeld I; Alm GV
    Int J Cancer; 1977 Aug; 20(2):309-17. PubMed ID: 70415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MCF-specific murine monoclonal antibodies made against AKR-247 MCF virus recognize a unique determinant associated with the gp70-p-15(E) complex.
    Cloyd MW; Chesebro B; Portis JL; Weir M
    J Virol; 1982 Mar; 41(3):1112-7. PubMed ID: 6178839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of nonresponsiveness to AKR/Gross leukemia virus in AKR.H-2b:Fv-1b mice. An analysis of precursor cytotoxic T lymphocyte frequencies in young versus moderately aged mice.
    Wegmann KW; McMaster JS; Green WR
    J Immunol; 1991 Apr; 146(7):2469-77. PubMed ID: 2005406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breakdown of Gross virus-induced tolerance in rats by inoculation of lymphoid cells.
    Takeichi N; Kuzumaki N; Kodama T; Kobayashi H
    J Natl Cancer Inst; 1974 Jun; 52(6):1817-22. PubMed ID: 4834410
    [No Abstract]   [Full Text] [Related]  

  • 26. Increase in Gross (G) antigen sites on the surface of AKR virus-induced rat lymphoma cells after treatment with trypsin.
    Brandchaft PB; Boone CW
    J Immunol; 1974 Jul; 113(1):94-102. PubMed ID: 4364955
    [No Abstract]   [Full Text] [Related]  

  • 27. AKR mouse leukemic cells in tissue culture. II. Immunologic studies on the AKR 87 cell line.
    Duś D; Harlozińska A; Skriabin A; Richter R
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):727-40. PubMed ID: 187141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marker chromosome analysis of tetraparental AKR leads to CBA-T6 mouse chimaeras.
    Ford CE; Evans EP; Burtenshaw MD; Clegg H; Barnes RD; Tuffrey M
    Differentiation; 1974 Dec; 2(6):321-33. PubMed ID: 4442678
    [No Abstract]   [Full Text] [Related]  

  • 29. The innate resistance of CBA mice to endogenous murine leukaemia virus infection.
    Barnes RD; Tuffrey M; Willis EJ; Mahouy G; Lasneret J
    Br J Cancer; 1976 Jul; 34(1):35-8. PubMed ID: 182192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. I. Isolation of a selectively resistant variant tumor subclone.
    Green WR
    Eur J Immunol; 1983 Nov; 13(11):863-70. PubMed ID: 6196206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autogenous immunity to endogenous RNA tumor virus. Radioimmune precipitation assay of mouse serum antibody levels.
    Ihle JN; Yurconic M; Hanna MG
    J Exp Med; 1973 Jul; 138(1):194-208. PubMed ID: 4352105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The humoral immune response of NIH Swiss and SWR/J mice to vaccination with formalinized AKR or Gross murine leukemia virus.
    Lee JC; Ihle JN; Huebner R
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):343-7. PubMed ID: 189311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extraction of gross surface antigens from AKR mouse lymphoma cells with potassium chloride.
    Brandchaft PB; Boone CW
    J Natl Cancer Inst; 1974 Oct; 53(4):1079-83. PubMed ID: 4427388
    [No Abstract]   [Full Text] [Related]  

  • 34. A shift in the requirement for CD4+ T cells in the generation of AKR/Gross MuLV-specific CTL in AKR.H-2b:Fv-1b mice occurs prior to the onset of age-dependent CTL nonresponsiveness.
    Smith PM; Rich RF; Green WR
    Cell Immunol; 1997 Feb; 175(2):189-98. PubMed ID: 9023425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphoma development from transplanted murine leukemia virus infected organ cultured thymuses: inhibitory effect of in vitro interferon treatment.
    Riesenfeld I; Tufveson G; Alm GV
    Int J Cancer; 1980 Apr; 25(4):529-34. PubMed ID: 6154660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunologic, virologic, and genetic aspects of mammary tumor virus-induced cell-surface antigens: presence of these antigens and the Thy 1.2 antigen on murine mammary gland and tumor cells.
    Hilgers J; Haverman J; Nusse R; van Blitterswijk WJ; Cleton FJ; Hageman PC; van Nie P; Calafat J
    J Natl Cancer Inst; 1975 Jun; 54(6):1323-33. PubMed ID: 166186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerance in tetraparental mouse chimaeras.
    Barnes RD
    Adv Exp Med Biol; 1976; 66():577-83. PubMed ID: 4965
    [No Abstract]   [Full Text] [Related]  

  • 38. The apparent lack of association of antibody activity to murine leukemia virus and lymphoma development in (AKR x CBA) F1 mice.
    Barnes RD; Tuffrey M; Holmes HC
    Eur J Cancer (1965); 1981 Jan; 17(1):93-8. PubMed ID: 6266833
    [No Abstract]   [Full Text] [Related]  

  • 39. Changes in expression of murine leukemia virus antigens and production of xenotropic virus in the late preleukemic period in AKR mice.
    Kawashima K; Ikeda H; Hartley JW; Stockert E; Rowe WP; Old LJ
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4680-4. PubMed ID: 188051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of CTL-defined, AKR/Gross retrovirus-associated tumor antigens by normal spleen cells: control by Fv-1, H-2, and proviral genes and effect on antiviral CTL generation.
    Green WR
    J Immunol; 1986 Jan; 136(1):308-12. PubMed ID: 2999246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.